02395nam 2200385 450 991068834940332120230626053137.0(CKB)5580000000514380(NjHacI)995580000000514380(EXLCZ)99558000000051438020230626d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierIdiopathic Pulmonary Fibrosis /edited by Salim Surani, Venkat RajasuryaLondon, England :IntechOpen,2022.1 online resource (218 pages)1-83969-241-3 1. Epidemiology of Idiopathic Pulmonary Fibrosis -- 2. Biomarkers in Idiopathic Pulmonary Fibrosis -- 3. Diagnosis of IPF -- 4. Pharmacological Management of Idiopathic Pulmonary Fibrosis -- 5. Acute Exacerbation of Idiopathic Pulmonary Fibrosis -- 6. Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis -- 7. Perspective Chapter: Pulmonary System and Sjogren's Syndrome -- 8. Lung Transplantation in Idiopathic Pulmonary Fibrosis.Idiopathic pulmonary fibrosis (IPF) affects 13-20 people per 100,000 population worldwide. In the United States, approximately 100,000 people have IPF with 30,000-40,000 new cases diagnosed annually. Diagnosis remains a challenge with a significant lag between symptoms onset and diagnosis. Delayed diagnosis and treatment can carry high morbidity and mortality. This book provides concise, easy-to-read, and up-to-date information as it relates to clinical presentation, diagnosis, and treatment of IPF. Despite, adequate treatment, the disease progresses, and a lung transplant is necessary in some cases. This book also discusses the role of lung transplants for IPF and its complications. It is a useful resource for primary care physicians, allied health professionals, hospitalists, and pulmonary physicians who take care of patients with IPF.Pulmonary fibrosisPulmonary fibrosisImmunological aspectsPulmonary fibrosis.Pulmonary fibrosisImmunological aspects.616.24Surani SalimRajasurya VenkatNjHacINjHaclBOOK9910688349403321Idiopathic Pulmonary Fibrosis1521745UNINA